rhNGF eye solution

recombinant human nerve growth factor (rhNGF) · Dompé Farmaceutici S.p.A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhNGF eye solution, covering 2022-02-08 to 2022-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye [Phase 2]

See pricing